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Mutations in structural proteins of SARS-CoV-2 and potential 
implications for the ongoing outbreak of infection in India 
Rimjhim Dasgupta 
4NBIO, 2502, Glen Classic, Hiranandani Gardens, Powai, Mumbai 400076 
Abstract 
SARS-CoV-2 has spread in India very quickly from its first reported case on 30 January 2020 in 
Thrissur, Kerala. With the drastic increasing number of positive cases around the world WHO raised 
the importance in the assessment of the risk of spread and understanding genetic modifications that 
could have occurred in the SARS-CoV-2. Using available genome sequence in NCBI repository from 
the samples of different locations in India, we identified the regions (hotspots) of the viral genome 
with high rates of mutation. We analysed four regions of the genome encoding structural proteins 
Spike (S), Nucleocapsid (N), envelop (E) and Membrane (M) proteins. Through computational 
biology approach, we identified multiple substitution mutations in S and N proteins whereas there is 
only one substitution in E protein and none in M protein.  We showed most of these amino acid 
residues are evolutionary conserved. The changes in the conserved residues may have significant 
implication on the stability of the proteins and subsequent interaction with other elements, which are 
essential for virus propagation. This provides a basis for a better understanding of the genetic 
variation in SARS-CoV-2 circulating in the India, which might provide important clues for 
identifying potential therapeutic targets, development of efficient vaccines, antiviral drugs and 
diagnostic assays for controlling COVID-19.  
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1 Introduction 
The pandemic Corona Virus Disease 2019 (COVID-19) caused by the RNA coronavirus severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV2), has spread over 200 countries and infected 
millions of people worldwide. The first case in India was reported on Jan 30 in Thrissur, Kerala and 
two other cases were reported by Feb 3, 2020. All of them were the students studying at a university 
in Wuhan, China and came home (Kerala) for vacation. As the number of the positive cases 
increasing drastically the World Health Organization (WHO) raised the importance of understanding 
genetic modification that could have occurred in the SARS-CoV-2 and whether the variations in 
genome sequences is impacting person to person transmission and mortality rate. Searching for 
mutations and their evolutionary conservation while the virus continues to spread within the country 
can offer opportunities for a better understanding of virus evolution, biopathology, and transmission. 
Having this motivation, considering Wuhan based genome NC_045512.2 as reference, we report on 
multiple missense mutations on structural proteins Spike (S), nucleocapsid (N) and envelope (E) in 
many Indian isolates and absent in the Chinese ones.  
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2 Methods 
Wuhan isolate, SARS-CoV-2 sequence NC_045512.2 (length 29903 nt) was used as a reference 
sequence and for sequence comparisons. For our study, we considered the sequences that were 
available in GISAID and NCBI. We first compared 20 available sequences from Wuhan. They 
showed 100% sequence similarities. In the present report we have focussed on sequence alignments, 
we have used NCBI BLAST, and CLUSTAL OMEGA. ~150 genome sequences (sourced from 
Global Initiative on Sharing All Influenza, GISAID, https://www.gisaid.org/ and NCBI) from 
different regions of India were considered for this study. 
3 Results 
We have taken attempt to conduct genomic comparison by considering ~150 SARS-Cov2 sequences 
from patient samples of different locations in India. Since COVID19 started from Wuhan, China, we 
started our analyses from sequences from Wuhan. We first compared 20 sequences of patient samples 
from Wuhan. It showed 100% sequence similarities (data not shown). We considered NC_045512.2 
as reference for our analysis.   
Our analysis revealed that several sites are possessing non-synonymous substitutions and associated 
amino acid changes. We analysed four regions of the genome encoding structural proteins, those are 
Spike (S), Nucleocapsid (N), envelop (E) and Membrane (M) proteins. Multiple non-synonymous 
substitutions were found in S and N proteins. The list of mutations detected in this set of sequences 
from ~150 samples are provided in Table 1 and table 2.  
Total 25 different missense mutations were found in S protein. Among them 8 are in N terminal 
domain (NTD) of S1 subunit, 3 (R407I, T572I, E583D) are in receptor binding domain (RBD), 1 is in 
C terminal of S1 subunit and 13 is in S2 domain. We found L54F, R78M, D614G mutations in 9%, 
4% and 90% of sequences respectively. L54F and R78M mutations were detected only in some 
patients in Gujarat. We noticed Y145Stop, R407I mutations in one sequence from Kerala 
(QHS34546.1). S162I substitution (polar to nonpolar) was observed in one sequence (QJY40469.1). 
2% of the sequences have T572I substitutions. All these also have D614G substitutions. 
 
Table 1: The list of mutations is placed in tabular form. Sequence ID is the accession number 
followed by sample location (patient sample location), mutated residue (single letter code for amino 
acid has been used) and region (region in protein sequence) 
 
Sequence ID Sample location Mutation Region 
QIA98583.1 Kerala A930V S2 domain 
QHS34546.1 Kerala Y145Stop, R407I, D614G, Junction of S1 & S2 
QJQ39968.1 Bangalore D614G Junction of S1 & S2 
QJQ39980.1 Bangalore D614G Junction of S1 & S2 
QJQ39992.1 Bangalore D614G Junction of S1 & S2 
QJF77858.1 Hyderabad D614G Junction of S1 & S2 
QJF77882.1 Hyderabad D614G Junction of S1 & S2 
QKQ30054.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30066.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30090.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30102.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30114.1 Ahmedabad D614G Junction of S1 & S2 
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QKQ30150.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30246.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30258.1 Ahmedabad D614G Junction of S1 & S2 
QKQ30270.1 Ahmedabad D614G Junction of S1 & S2 
QKQ63388.1 Ahmedabad D614G Junction of S1 & S2 
QJQ28345.1 Ahmedabad D614G Junction of S1 & S2 
QJQ28357.1 Ahmedabad D614G Junction of S1 & S2 
QJQ28369.1 Ahmedabad D614G Junction of S1 & S2 
QJQ28381.1 Ahmedabad D614G Junction of S1 & S2 
QJQ28405.1 Ahmedabad D614G Junction of S1 & S2 
QKY60165.1 Bharuch D614G Junction of S1 & S2 
QJW00363.1 Dahegam D614G Junction of S1 & S2 
QJW00375.1 Dahegam D614G Junction of S1 & S2 
QJW00387.1 Dahegam D614G Junction of S1 & S2 
QKV25909.1 Ahmedabad D614G Junction of S1 & S2 
QKV27563.1 Dhanera D614G Junction of S1 & S2 
QKV25945.1 Vadodara D614G Junction of S1 & S2 
QKV25957.1 Vadodara D614G Junction of S1 & S2 
QKV25981.1 Vadodara D614G Junction of S1 & S2 
QKV26029.1 Vadodara D614G Junction of S1 & S2 
QKV26041.1 Vadodara D614G Junction of S1 & S2 
QKV26065.1 Vadodara D614G Junction of S1 & S2 
QKV26089.1 Vadodara D614G Junction of S1 & S2 
QKG91214.1  Himatnagar D614G Junction of S1 & S2 
QKI28661.1  Himatnagar D614G Junction of S1 & S2 
QJS39639.1 Hyderabad D614G Junction of S1 & S2 
QJY40421.1 Jamnagar D614G Junction of S1 & S2 
QJY40445.1 Jamnagar D614G Junction of S1 & S2 
QJY40505.1 Junagadh D614G Junction of S1 & S2 
QKQ29946.1 Kadi D614G Junction of S1 & S2 
QKQ29958.1 Kadi D614G Junction of S1 & S2 
QKQ30042.1 Kalol D614G Junction of S1 & S2 
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QKQ30174.1 Kalol D614G Junction of S1 & S2 
QKQ30198.1 Kalol D614G Junction of S1 & S2 
QKH78810.1 Khedbrahma D614G Junction of S1 & S2 
QKI28637.1 Khedbrahma D614G Junction of S1 & S2 
QJY40385.1 Kodinar D614G Junction of S1 & S2 
QKY64792.1 Mandvi D614G Junction of S1 & S2 
QJW00447.1 Mansa D614G Junction of S1 & S2 
QJQ28429.1 Mansa D614G Junction of S1 & S2 
QJW39904.1 Modasa D614G Junction of S1 & S2 
QKY74628.1 Palanpur D614G Junction of S1 & S2 
QKY59941.1 Palanpur D614G Junction of S1 & S2 
QJW39916.1 Prantij D614G Junction of S1 & S2 
QJT43680.1 Prantij D614G Junction of S1 & S2 
QKJ68485.1 Rajkot D614G Junction of S1 & S2 
QKY60049.1 Surat D614G Junction of S1 & S2 
QKY60085.1 Surat D614G Junction of S1 & S2 
QJY40529.1 Una D614G Junction of S1 & S2 
QJY40577.1 Una D614G Junction of S1 & S2 
QJY51288.1 Vadodara D614G Junction of S1 & S2 
QJY51348.1 Vadodara D614G Junction of S1 & S2 
QJY51384.1 Vadodara D614G Junction of S1 & S2 
QKY65277.1 Bhuj D614G Junction of S1 & S2 
EPI_ISL_430465 Kolkata D614G Junction of S1 & S2 
EPI_ISL_430467 Kolkata D614G Junction of S1 & S2 
EPI_ISL_430468 Kolkata D614G, G1124V Junction of S1 & S2, S2 
EPI_ISL_430464 Kolkata D614G, G1124V Junction of S1 & S2, S2 
QKQ30078.1 Ahmedabad E583D, D614G RBD, Junction of S1 & S2 
QKQ30222.1 Ahmedabad E583D, D614G RBD, Junction of S1 & S2 
QJW00327.1 Himatnagar E583D, D614G RBD, Junction of S1 & S2 
QJQ27854.1 Bangalore K187X, D614G NTD, Junction of S1 & S2 
QKV25969.1 Vadodara L54F, D614G NTD, Junction of S1 & S2 
QKJ84943.1 Himatnagar L54F, D614G NTD, Junction of S1 & S2 
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QKJ84979.1 Himatnagar L54F, D614G NTD, Junction of S1 & S2 
QKY64614.1 Kheda L54F, D614G NTD, Junction of S1 & S2 
QKY64640.1 Kheda L54F, D614G NTD, Junction of S1 & S2 
QKY74640.1 Palanpur L54F, D614G NTD, Junction of S1 & S2 
QKY60213.1 Savli L54F, D614G NTD, Junction of S1 & S2 
QKY60225.1 Savli L54F, D614G NTD, Junction of S1 & S2 
QKY60025.1 Surat L54F, D614G NTD, Junction of S1 & S2 
QKY60073.1 Surat L54F, D614G NTD, Junction of S1 & S2 
QKY60201.1 Vadodara L54F, D614G NTD, Junction of S1 & S2 
QKY60237.1 Vadodara L54F, D614G NTD, Junction of S1 & S2 
QKY60264.1 Vadodara L54F, D614G NTD, Junction of S1 & S2 
QKI28601.1 Jamnagar L5F, T572I, D614G 
NTD, RBD, Junction of S1 & 
S2 
QJY40469.1 Jamnagar L5F, S162I, D614G 
NTD, RBD, Junction of S1 & 
S2 
QJY40409.1 Una Q677H S2 domain 
QJW69139.1 Modasa 
R78M, D614G, Q784X, V785X, 
K786X, Q787X, I788X, Y789X,  NTD, S2 domain 
QJW00315.1 Modasa R78M, D614G NTD, Junction of S1 & S2 
QJW39892.1 Modasa R78M, D614G NTD, Junction of S1 & S2 
QJW39928.1 Modasa R78M, D614G NTD, Junction of S1 & S2 
QJT43704.1 Modasa R78M, D614G NTD, Junction of S1 & S2 
QJT43716.1 Modasa R78M, D614G NTD, Junction of S1 & S2 
QJY77055.1 Jamnagar 
D614G, K811X, P812X, S813X, 
K814X, R815X S2 domain 
QKQ30126.1 Ahmedabad T572I, D614G,  RBD, Junction of S1 & S2 
QKQ30186.1 Ahmedabad T572I, D614G,  RBD, Junction of S1 & S2 
QKV27587.1 Nadiad W152L, D614G NTD, Junction of S1 & S2 
QJF77846.1 Hyderabad Y28H NTD 
We conducted multiple sequence alignment of S proteins to analyse the evolutionary conservation of 
amino acid residues for many of these mutations (Figure 1).  Our sequence alignment result shows 
that Leucine at position 5 is evolutionary conversed through bat, pangolin, SARS-Cov, SARS-CoV2, 
Leucine at 54F is conserved in RatG13, pangolin, MERS-CoV, SARS-CoV and SARS-CoV2, 
Arginine in position 78 is conserved in bat and SARS-CoV2, Tyrosine at 146 is conserved in bat, 
pangolin and SARS-CoV2, Arginine at position 408 is conserved in bat, pangolin, SARS-Cov, SARS-
CoV2, Threonine at 572 is conserved in bat, pangolin and SARS-CoV2, Aspartic acid at position 614 
is conversed in bat, pangolin, SARS-Cov, SARS-CoV2, Glycine at 1124 is conversed in bat, 
pangolin, SARS-Cov, SARS-CoV2. 
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AFS88936.1_MERS-CoV      MIHSVFLLMFLLTPTESYVDVGPDSVKSACIEVDIQQTFFDKTWPRPIDVSKADGIIYPQ 60 
AAP30030.1_SARS-CoV      ----MFIFLLFL-TLTSGS------DLDRCTTFDDVQ-----APNYTQHTSSMRGVYYPD 44 
QIA48614.1_Pangolin      ----MFVFLFVL-PLVSSQ----------CVNLTTRT-----GIPPGYTNSSTRGVYYPD 40 
QHR63300.2_RaTG13        ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSSTRGVYYPD 40 
QHS34546.1               ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
YP_009724390.1_Ref       ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
QKY60264.1               ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
EPI_ISL_430464           ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
QJW00315.1               ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
QKQ30126.1               ----MFVFLVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
QKI28601.1               ----MFVFFVLL-PLVSSQ----------CVNLTTRT-----QLPPAYTNSFTRGVYYPD 40 
                                                                                        5 
AFS88936.1_MERS-CoV      GRTYSNITITYQGLF-PYQGDHGDMYVYSAGHATGTTPQKLFVANYSQDVKQFANGFVVR 119 
AAP30030.1_SARS-CoV      EIFRSDTLYLTQDLFLPFYSNV---TGFHTIN-------HT----FDNPVIPFKDGIYFA 90 
QIA48614.1_Pangolin      KVFRSSILHLTQDLFLPFFSNV---TWFNTINYQG--GFKK----FDNPVLPFNDGVYFA 91 
QHR63300.2_RaTG13        KVFRSSVLHLTQDLFLPFFSNV---TWFHAIHVSGTNGIKR----FDNPVLPFNDGVYFA 93 
QHS34546.1               KVFRSSVLHSTQDLFLPFFSNV---TWFHAIHVSGTNGTKR----FDNPVLPFNDGVYFA 93 
YP_009724390.1_Ref       KVFRSSVLHSTQDLFLPFFSNV---TWFHAIHVSGTNGTKR----FDNPVLPFNDGVYFA 93 
QKY60264.1               KVFRSSVLHSTQDFFLPFFSNV---TWFHAIHVSGTNGTKR----FDNPVLPFNDGVYFA 93 
EPI_ISL_430464           KVFRSSVLHSTQDLFLPFFSNV---TWFHAIHVSGTNGTKR----FDNPVLPFNDGVYFA 93 
QJW00315.1               KVFRSSVLHSTQDLFLPFFSNV---TWFHAIHVSGTNGTKM----FDNPVLPFNDGVYFA 93 
QKQ30126.1               KVFRSSVLHSTQDLFLPFFSNV---TWFHAIHVSGTNGTKR----FDNPVLPFNDGVYFA 93 
QKI28601.1               KVFRSSVLHSTQDLFLPFFSNV---TWFHAIHVSGTNGTKR----FDNPVLPFNDGVYFA 93 
                                                                                                    54                                                                   78 
AFS88936.1_MERS-CoV      LRA--FYCILEPRSGNHCPAGNSYTSFATYHTPATDCSDGNYNRNASLNSFKEYFNLRNC 237 
AAP30030.1_SARS-CoV      IRACNFELCDNPFFAVSKPMG---------------------T----QTHTMIFDNAFNC 159 
QIA48614.1_Pangolin      IKVCEFQFCTDPFLGVYYHNN---------------------NKTWVENEFRVYSSANNC 164 
QHR63300.2_RaTG13        IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
QHS34546.1               IKVCEFQFCNDPFLGVY-HKN---------------------NKSWMESEFRVYSSANNC 165 
YP_009724390.1_Ref       IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
QKY60264.1               IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
EPI_ISL_430464           IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
QJW00315.1               IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
QKQ30126.1               IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
QKI28601.1               IKVCEFQFCNDPFLGVYYHKN---------------------NKSWMESEFRVYSSANNC 166 
                                                                                                             146 
AFS88936.1_MERS-CoV      RFVYDAYQNLVGYYSD--DGNYYCLRACVSVPVSVIYD--KETKTHATLFGSVACEHISS 684 
AAP30030.1_SARS-CoV      QFGRDVSDFTD-SVRDPKTSEILDISPCSFGGVSVITPGTNASSEVAVLYQDVNCTDVST 608 
QIA48614.1_Pangolin      QFGRDISDTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPM 620 
QHR63300.2_RaTG13        QFGRDIADTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNASNQVAVLYQDVNCTEVPV 622 
QHS34546.1               QFGRDIADTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPV 621 
YP_009724390.1_Ref       QFGRDIADTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPV 622 
QKY60264.1               QFGRDIADTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPV 622 
EPI_ISL_430464           QFGRDIADTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPV 622 
QJW00315.1               QFGRDIADTTD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPV 622 
QKQ30126.1               QFGRDIADITD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPV 622 
QKI28601.1               QFGRDIADITD-AVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPV 622 
                                                                                                                                                                                                       614 
AFS88936.1_MERS-CoV      CIAPVNGYFIKTNNTRIVDEWSYTGSSFYAPEPITSLNTKYVAPQVTYQN-ISTNLPPPL 1222 
AAP30030.1_SARS-CoV      -YFPREGVFVFN-----GTSWFITQRNFFSPQIITTDNTFVSGNCDVVIGIINNTVYDPL 1123 
QIA48614.1_Pangolin      -HFPREGVFVSN-----GTHWFITQRNFYEPQIITTDNTFVSGSCDVVIGIVNNTVYDPL 1135 
QHR63300.2_RaTG13        -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGSCDVVIGIVNNTVYDPL 1137 
QHS34546.1               -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL 1140 
YP_009724390.1_Ref       -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL 1141 
QKY60264.1               -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL 1141 
EPI_ISL_430464           -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSVNCDVVIGIVNNTVYDPL 1141 
QJW00315.1               -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL 1141 
QKQ30126.1               -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL 1141 
QKI28601.1               -HFPREGVFVSN-----GTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPL 1141 
                                                                                                                                                                               1124 
 
Figure 1: Alignment of S proteins (MERS-CoV accession # AFS88936.1; SARS-CoV accession # 
AAP30030.1; Pangolin coronavirus accession # QIA48614.1; Bat coronavirus RaTG13 accession # 
QHR63300.2; SARS-CoV2 REFSEQ: accession NC_045512.2  accession # YP_009724390.1; 
SARS-CoV2 accession # QHS34546.1 of Kerala patient sample; SARS-CoV2 accession # 
QKY60264.1 of Vadodara patient sample; SARS-CoV2 accession # EPI_ISL_430464 Kolkata patient 
sample; SARS-CoV2 accession # QJW00315.1 Modasa patient sample; SARS-CoV2 accession # 
QKQ30126.1 Ahmedabad patient sample; SARS-CoV2 QKI28601.1 Bayad patient sample); Mutated 
conserved amino acid positions are highlighted in green and mutated amino acids are in pink 
highlight; The numbers below the alignments denote the residue position of corresponding to SARS-
CoV-2 S protein 
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  Total 23 different missense mutations were found in nucleocapsid (N) protein. One sample from 
Gujarat (QKI28681.1) has P6T mutation, nonpolar to polar amino acid. P13L mutation was found in 
10% sequences. D22Y and D22N were found in 2 sequences and both also have additional mutations. 
S33I mutation was found in 2 sequences and these do not have any additional mutation in N protein. 
4% sequences have S194L (polar to non-polar) mutation and among them 6% also has S202N (both 
are polar but Ser is polar neutral whereas Arg is hydrophilic) mutation. Two mutations, R203K and 
G204R were found in ~6% of ~150 sequences. Sample locations are Gujarat, Bangalore, Pune, Delhi 
and Kolkata.  
   We also conducted multiple sequence alignment of N proteins to analyse the evolutionary 
conservation of amino acid residues for many of these mutations. Our result shows that Proline at 
position 6, 13 are conversed in bat, pangolin, SARS-Cov, SARS-CoV2; Aspartic acid at position 22 is 
conversed in bat, pangolin, MERS-CoV, SARS-Cov, SARS-CoV2; serine at  position 194, Glycine at 
position 204 are conserved in are conversed in bat, pangolin, MERS-CoV, SARS-Cov, SARS-CoV2; 
Arginine is conversed in bat, pangolin, SARS-Cov, SARS-CoV2 (Figure 2) 
AFS88943.1_MERS-CoV      ------MASPAAPRAVSFADNNDITNTN----LSRGRGRNPKPRAAPNNTVSWYTGLTQH 50 
AAP30037.1_SARS-CoV      MSDNGPQSNQRSAPRITFGGPTDSTDNNQNGGRNGARPKQRRPQGLPNNTASWFTALTQH 60 
QIG55953.1_Pangolin      MSDNGPQ-NQRNAPRITFGGPSDSAGSNQNGERSGARPKQRRPQGLPNNTASWFTALTQH 59 
QHR63308.1_RaTG13        MSDNGPQ-NQRNAPRITFGGPSDSTGSNQNGERSGARPKQRRPQGLPNNTASWFTALTQH 59 
QKY74648.1               MSDNGPQ-NQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQH 59 
QKY60069.1               MSDNGPQ-NQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQH 59 
QJY40417.1               MSDNGPQ-NQRNALRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQH 59 
QKY60093.1               MSDNGPQ-NQRNAPRITFGGPSNSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQH 59 
YP_009724397.2_Ref       MSDNGPQ-NQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQH 59 
QKI28681.1               MSDNGTQ-NQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQH 59 
                                                                                6                 13                    22 
AFS88943.1_MERS-CoV      SQSSSRASSLSRNSSRSSSQGSRSGNSTRGTSPGPSGIGAVGGDLLYLDLLNRLQALESG 228 
AAP30037.1_SARS-CoV      SQASSRSSSRSRGNSRNSTPGSSRGNSPARMA---SGGGETALALLLLDRLNQLESKVSG 237 
QIG55953.1_Pangolin      SQASSRSSSRSRNSSRNTTPGSSRGTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
QHR63308.1_RaTG13        SQASSRSSSRSRNSSRNSTPGSSRGTSPARMA---GNGSDAALALLLLDRLNQLESKMSG 236 
QKY74648.1               SQASSRSSSRSRNSLRNSTPGSSGRTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
QKY60069.1               SQASSRSSSRSRNSLRNSTPGSNRGTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
QJY40417.1               SQASSRSSSRSRNSSRNSTPGSSRGTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
QKY60093.1               SQASSRSSSRSRNSLRNSTPGSSRGTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
YP_009724397.2_Ref       SQASSRSSSRSRNSSRNSTPGSSRGTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
QKI28681.1               SQASSRSSSRSRNSSRNSTPGSSRGTSPARMA---GNGGDAALALLLLDRLNQLESKMSG 236 
                                                                                                     194              202-204 
Figure 2: Alignment of N proteins (MERS-CoV accession # AFS88943.1; SARS-CoV accession # 
AAP30037.1; Pangolin coronavirus accession # QIG55953.1; Bat coronavirus RaTG13 accession # 
QHR63308.1; SARS-CoV2 REFSEQ: accession NC_045512.2  accession # YP_009724397.2; 
SARS-CoV2 accession # QKY74648.1 of Palanpur patient sample; SARS-CoV2 accession # 
QJY40417.1 of Una patient sample; SARS-CoV2 accession # QKY60093.1 of Surat patient sample; 
SARS-CoV2 accession # QKY60069.1 of Surat patient sample; SARS-CoV2 accession # 
QKI28681.1 of Khedbrahma patient sample; Mutated conserved amino acid positions are highlighted 
in green and mutated amino acids are in pink highlight; The numbers below the alignments denote the 
residue position of corresponding to SARS-CoV-2 N protein 
 
SARS- CoV2 envelope (E) protein is a small, integral membrane protein involved in several aspects 
of the virus’ life cycle, such as assembly, budding, envelope formation, and pathogenesis. One 
substitution (V62F) was found at the C terminal end in one sample from Gujarat (Figure 3) 
                                                               62 
 
         
Figure 3: Alignment of C terminal end of E protein shows substitution mutation V62F (SARS-CoV2 
accession # QKV26079.1 of Nadiad patient sample with Reference sequence NC_045512.2 accession 
# YP_009724392.1); Mutated residue in pink highlight; The numbers above the alignment denote the 
residue position of corresponding to SARS-CoV-2 E protein 
   The important point to note here that most of the patient samples where mutations were identified 
either have international travel history or direct contact to the person travelled. 
QKV26079.1    RFKNLNSSRVPDLLV 75 
NC_045512_E RVKNLNSSRVPDLLV 75  
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Table 2: The list of mutations is placed in tabular form. Sequence ID is the accession number 
followed by sample location (patient sample location), mutated residue (single letter code for amino 
acid has been used) and region (region in protein sequence) 
Sequence ID Sample location Mutation Region 
QKI28681.1 Khedbrahma P6T NTD 
QJU70565.1 Hyderabad P13L NTD 
QJQ27850.1 Bangalore P13L NTD 
QJQ27874.1 Bangalore P13L NTD 
QJQ27886.1 Bangalore P13L NTD 
QJF77878.1 Hyderabad P13L NTD 
QJF11844.1 Bangalore P13L NTD 
QJF11856.1 Bangalore P13L NTD 
QJF11868.1 Bangalore P13L NTD 
QJR84533.1 Ahmedabad P13L NTD 
QJY40405.1 Botad P13L NTD 
QJS39659.1 Hyderabad P13L NTD 
QJT43688.1 Prantij P13L NTD 
QJQ28437.1 Mansa P13R NTD 
QJY77063.1 Jamnagar P13L NTD 
QJY40417.1 Una P13L, A146S NTD, RNA binding domain 
QKQ30158.1 Ahmedabad D22Y, S194L NTD, Linker peptide  
QKY60093.1 Surat D22N, L139F, S194L 
NTD, RNA binding domain, 
Linker peptide  
QJQ28377.1 Ahmedabad S33I NTD 
QJQ28389.1 Ahmedabad S33I NTD 
QKV26073.1 Vadodara A134V RNA binding domain 
QJF77854.1 Hyderabad P344S dimerization domain (DD) 
QJW69147.1 Modasa 
D399X, L400X, 
D401X, D402X, F403X, 
S404X, K405X, Q406X, 
L407X,  
C terminal end  
QKY60069.1 Surat S194L, S202N Linker peptide  
QJY40429.1 Jamnagar S194L, D348Y 
Linker peptide, dimerization 
domain (DD) 
QKI28669.1 Himatnagar S194L Linker peptide  
QKY74648.1 Palanpur S194L, R203G, G204R Linker peptide  
QJY40585.1 Una R203K, G204R Linker peptide  
QJY40537.1 Una R203K, G204R Linker peptide  
QKY74636.1 Palanpur R203K, G204R Linker peptide  
QKY64800.1 Mandvi R203K, G204R Linker peptide  
QJF11880.1 Bangalore R203K, G204R Linker peptide  
QJF11832.1 Bangalore R203K, G204R Linker peptide  
QJF11820.1 Bangalore R203K, G204R Linker peptide  
QJH92187.1 Pune R203K, G204R Linker peptide  
EPI_ISL_430468 Kolkata R203K, G204R Linker peptide  
EPI_ISL_430464 Kolkata R203K, G204R Linker peptide  
EPI_ISL_430465 Kolkata R203K, G204R Linker peptide  
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4 Discussion 
   Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is being intensively studied, 
particularly its evolution, in the increasingly available sequences with classical phylogenetic tree 
representation. We report here certain protein mutations which could have potential structural and/or 
functional implication. 
4.1 Mutations in Spike protein and potential implication  
   Coronavirus entry into host cells is mediated by the transmembrane spike (S) glycoprotein that 
forms homotrimers protruding from the viral surface (Tortorici and Veesler, 2019). 
S comprises two functional subunits, responsible for binding to the host cell receptor (S1 subunit) and 
fusion of the viral and cellular membranes (S2 subunit). For many Coronaviruses, S is cleaved at the 
boundary between the S1 and S2 subunits, which 
remain non-covalently bound in the prefusion conformation. This region is reported to be the most 
potent and indispensable for viral attachment and entry into host system (Walls et al., 2020). The 
miss-sense mutations in S protein those we report are mostly single point mutations with few double 
and triple mutations. All these mutations could be classified as stabilizing and destabilizing based on 
the free-energy changes. 
   We found L5F, L54F substitutions in 1.5% and 9% sequences considered in this study. Both amino 
acids are non-polar, but phenylalanine has a benzoic ring in the side chain which may stiffen the 
secondary structure by means of aromatic-aromatic, hydrophobic or stacking interactions. Earlier 
report in Non- Structural Protein 6 (NSP6) by amino acid change stability (ACS) analysis showed that 
this (leucine to phenylalanine) leads to a lower stability of the protein structure (Benvenuto et al. 
2020). We noticed R78M mutation in 4% of the sequences studied. Arginine (R) is basic, hydrophilic 
whereas methionine (M) is nonpolar hydrophobic.  Other mutations in N terminal domain (NTD) 
includes Y145Stop, W152L, S162I, K187X. Previous study (Walls et al., 2020) showed a high 
thermal factor for the NTD (through the cryo-EM structure of the S protein). As these mutations are 
found at NTD, this observation puts an open question, whether the virus adopts viability through 
mutations, stabilizing the flexible NTD.  
   The receptor-binding domain or RBD of the Spike protein of SARS-CoV-2 lies between amino 
acids 330 and 583. We found R407I, T572I, E583D mutations in RBD. The high-temperature factor 
of RBD was reported earlier (Walls et al., 2020) which is associated with its dynamic nature leading 
to the conformational switch between close and open states. All three substitutions we report here, lie 
in the RBD, which could be corelated with the alteration in receptor binding affinity. Arginine 
(R407I) is a positively charged amino acid and Isoleucine is a hydrophobic amino acid. While 
positively charged amino acid could be more exposed, hydrophobic amino acids secure themselves 
away from the outer aqueous environment. For T572I, Threonine is polar and Isoleucine is a 
hydrophobic amino acid. Recent report suggests that S protein binds to ACE2 (angiotensin converting 
enzyme 2) through Leu455, Phe486, Gln493, Asn501, and Tyr505 (Liu et al. 2020). This substitution 
mutation of neighbouring residues may impact host receptor interaction by altering the protein 
conformation. All together these may potentially impact on the binding affinity to host receptor. 
     D614G substitution was observed in ~90% sequences studied in our analysis.  It occurs either as a 
single mutation or coupled with other mutations (L5F/S162I/D614G, L54F/D614G, R78M/D614G, 
W152L/D614G, E583D/D614G, Y145Stop/R407I/D614G). Laha et al (2020) showed that the change 
from Aspartic acid to Glycine alters the electro-static potential of the surface of the protein. This 
change creates a favourable environment in a hydrophobic pocket of the S protein. Another report 
(Flores and Cardozo 2020) revealed that the amino acid at position 614 occurs at an internal protein 
interface of the viral spike, and the presence of G at this position destabilises a specific conformation, 
within which the key host receptor binding site is more accessible. It makes G614 is a more 
pathogenic. In this study we have seen that L5F, L54F, R78M mutations are individually coupled with 
D614G. Earlier (Benvenuto et al. 2020) ACS analysis showed that leucine to phenylalanine leads to a 
lower stability of the protein structure. There is possibility that D614G coupled with Leucine to 
Phenylalanine mutation brings more favourable environment to enhance accessibility to host receptor 
and makes the virus more infectious. 
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   Another substitution Q677H was observed in one sequence of patient sample from Una. This 
position lies at the junction of S1 and S2 subunit in the vicinity of furin cleavage site, which plays an 
important role in virus entry. Glutamine is polar whereas Histidine is a basic hydrophilic amino acid. 
It was reported earlier that glutamine to histidine in H1N1 had a severe impact in virus entry 
replication and cross infectivity to other species (Tiwari and Mishra, 2020). Whether both these 
mutations (D614G, Q677H) have resulted in the evolution of a more stable and transmissible viral 
subtype needs investigation. 
   Mutation A930V was found in the sequence (QIA98583.1) from Kerala sample which falls in the S2 
subunit. Considering the nature of valine being destabilizing causing distortion (Laha et al 2020), this 
mutation might have implications in viral membrane fusion. The residue alanine at position 930 
stabilizes the protein due to its hydrophobic nature. On substitution with Valine in the same position, 
it can potentially change the affinity of the molecule toward its receptor. Secondly this substitution 
was observed only in QIA98583.1 (patient from Kerala who was studying in Wuhan). Interestingly 
this sequence doesn’t have D614G mutation.   We have not found D614G or any other mutations (we 
reported here) in any Chinese sequences studied in this study whereas many of these including D614G 
are reported in sequences from other countries (Flores and Cardozo 2020). Probably this is the 
indication that the virus is getting mutated after multiple passages. Our multiple sequence alignment 
shows that the amino acid residues which had undergone mutations, are evolutionary conserved 
(Figure 1). This implies the significance of these residues in respective positions. Any alteration could 
impact the structural and functional conformation of the protein which makes it more infectious. 
 
   Although the clinical significance of the observed mutations is not readily available, our findings in 
Indian patients lay the ground work for India to understand the impact of SARS-CoV2 mutations on 
disease severity, host immune response, vaccine development and serological response. 
    
4.2   Mutations in Nucelocapsid (N) protein and potential structural and functional 
implication  
   The nucleocapsid protein is an important structural protein for the coronaviruses. It is highly 
abundant in the viruses. Its function involves entering the host cell, binding to the RNA, and forming 
the ribonucleoprotein core. It consists of RNA binding domain (RBD; residues 44-180) in the N-
terminal region (N) of the protein, linker peptide (residues 181-246), the dimerization domain (DD; 
residues 247-364) in the C-terminal region (Zeng et al. 2020). Three disordered regions were reported 
on 1) N terminal (residues 1-43), 2) linker peptide, and 3) C terminal end (residues 365-419).  
   We found P6T, P13L, D22Y, D22N, S33I in first disordered region, A134V, L139F, A146S in 
RBD, S194L, S202N, R203G, G204R in linker (second disordered region), P344S, D348Y in 
dimerization domain and D399X, L400X, D401X, D402X, F403X, S404X, K405X, Q406X, L407X 
in 3rd disordered region . R203K/G and G204R mutations were observed in ~6% sequences. 
Sometimes it is coupled with S194L. Triple base mutations of 2881-2883 GGG/AAC was detected in 
coding region that results in two consecutive amino acid changes, R203K and G204R. The sites of 
these mutations are located in the SR-rich intrinsically disordered region (Chang et al. 2014). 
Moreover, this region surrounds with GSK3 phosphorylation ‘SRGTS’ (amino acid position 202-206) 
and CDK phosphorylation ‘SPAR’ (amino acid position 206-209) motifs (Surjit et al. 2005). When 
Ser202 is phosphorylated it incorporates a large negative group tethered to the sidechain of Ser, as 
seen in many other substrates of kinases. Arg203 is a part of GSK3 phosphorylation motif and its 
sidechain could potentially contribute to charge neutralization at phosphorylated-Ser202. 
    Earlier structural study (Zeng et al. 2020) reports that multiple disordered regions facilitate the N 
protein to transiently bind to different partners and maintain a correct conformation. Since we report 
multiples mutations in these disordered regions, possibly it impacts the binding of different partners to 
attain the correct conformation. Our protein alignment study shows that most of the positions in which 
point mutations occurred are conserved in bat, pangolin, SARS-Cov and MERS-CoV (Figure 2). It 
implies the structural and functional significance of these residues for protein stability and interaction 
with binding partners.  
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4.3  Mutation in envelope (E) protein and its potential implication 
 The envelope (E) protein is a small, integral membrane protein involved in several aspects of the 
virus’ life cycle, such as assembly, budding, envelope formation, and pathogenesis. Recent studies 
have reported its structural motifs and topology. The report also showed its function as an ion-
channelling viroporin, and it interacts with both other coronaviruses (MERS-CoV, SARS-CoV) 
proteins and host cell proteins (Schoeman and Fielding 2019). The SARS-CoV E protein consists of 
three domains, i.e. the amino (N)-terminal domain (residues ~1-8), the transmembrane domain (TMD, 
residues 9 -38)), and the carboxy (C)-terminal domain (residues 39- 75) (Schoeman and Fielding 
2019). We found one substitution (V62F) at the C-terminus in one sequence of patient sample from 
Gujarat. Earlier study showed that V25F hampers the oligomerisation of SARS-CoV E, to some 
extent. It was also reported that SARS-CoV E protein contain a binding motif known as the 
postsynaptic density protein 95 (PSD95)/Drosophila disc large tumour suppressor (Dlg1)/zonula 
occludens-1 protein (zo-1) (PDZ)-binding motif (PBM), located in the last four amino acids of the C 
terminus (Schoeman and Fielding 2019). The PBM motif can bind to the C-terminus of target proteins 
such as the cellular adapter proteins involved in host-cell processes important for viral infection. We 
identified the similar motif ‘DLLV’ (residues: 72-75) at the C-terminus in all the sequences of SARS-
COV2 analysed in this study (Figure 3). V62F can potentially interfere the interaction with target 
proteins thereby altering the host-cell processes required for viral infection. 
This analysis does not find any mutation in Membrane (M) protein in the sequences from ~150 patient 
samples of different regions in India. This implies that M protein is comparably stable but needs 
further investigation by increasing sample size and covering more locations. 
5 Conclusion 
All together our findings provide leads which might benefit outbreak tracking, development of 
therapeutic and prophylactic strategies against the infection. These mutations in the conserved amino 
acids, likely developed during virus spread, could affect virus host receptor interaction, stability, 
intracellular survival. This report provides important insights for functional validation to understand 
the molecular basis of differential disease severity. Genome follow-up of SARS-CoV-2 spread is 
urgently needed in order to identify mutations that could significantly modify virus pathogenicity. 
This study also warrants the importance of sequencing the whole genome of SARS-CoV-2 after 
several passages and key mutations should be noted for the effective drug designing and treatment 
options such as antiviral and immune therapy. The high mortality rate, along with their ease of 
transmission, underpins the need for more research into SARS-Cov2 molecular biology which can aid 
in the production of effective anti-coronaviral agents. 
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